Page last updated: 2024-08-23

pimonidazole and Neoplasms, Otorhinolaryngologic

pimonidazole has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, M; Böke, S; Helbig, L; Koi, L; Sriramareddy, SN; Thames, HD; Yaromina, A; Zips, D	1

Other Studies

1 other study(ies) available for pimonidazole and Neoplasms, Otorhinolaryngologic

Article	Year
Prognostic value of HIF-1α expression during fractionated irradiation. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2012, Volume: 188, Issue:11 Topics: Animals; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Dose Fractionation, Radiation; Female; Gene Expression; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Otorhinolaryngologic Neoplasms; Prognosis; Radiation-Sensitizing Agents; Statistics as Topic; Transplantation, Heterologous	2012

Article

Year

Prognostic value of HIF-1α expression during fractionated irradiation.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2012, Volume: 188, Issue:11

Topics: Animals; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Dose Fractionation, Radiation; Female; Gene Expression; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Otorhinolaryngologic Neoplasms; Prognosis; Radiation-Sensitizing Agents; Statistics as Topic; Transplantation, Heterologous

2012